AAV Gene Therapy with Cholesterol 24-Hydroxylase for Alzheimer Disease: In Vivo Consequences on Amyloid and Tau Components of the Pathology

被引：0
|
作者：
Gautier, Benoit [1 ]
Burlot, Marie Anne [1 ]
Blum, David [2 ]
Hudry, Eloise [1 ]
Ayciriex, Sophie [3 ]
Troquier, L. [2 ]
Zommer, N. [2 ]
Caillerez, R. [2 ]
Auzeil, Vincent [3 ]
Braudeau, Jerome [1 ]
Laprevote, Olivier [3 ]
Pradier, Laurent
Aubourg, Patrick [1 ]
Buee, Luc [2 ]
Cartier, Nathalie [1 ]
机构：
[1] Univ Paris 05, INSERM, UMR745, Paris, France
[2] Univ Lille 2, INSERM, UMR837, F-59800 Lille, France
[3] Univ Paris 05, Lab Chim Toxicol Analyt & Cellulaire C TAC EA 446, Paris, France
来源：
MOLECULAR THERAPY | 2012年 / 20卷
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
74
引用
收藏
页码：S30 / S31
页数：2
相关论文
共 28 条
  • [1] AAV gene therapy for Alzheimer disease: Consequences of AAV-mediated CHOLESTEROL 24-HYDROXYLASE overexpression in THY-TAU22 mouse model.
    Burlot, Marie-Anne
    Blum, David
    Braudeau, Jerome
    Ayciriex, Sophie
    Bieche, Ivan
    Varin, Jennifer
    Gautier, Benoit
    Troquier, Laetitia
    Zommer, Nadege
    Caillerez, Raphaelle
    Pradier, Laurent
    Aubourg, Patrick
    Laprevote, Olivier
    Auzeil, Nicolas
    Buee, Luc
    Cartier, Nathalie
    HUMAN GENE THERAPY, 2012, 23 (10) : A37 - A37
  • [2] AAV gene therapy with cholesterol 24-hydroxylase attenuates Alzheimer phenotype in APP23 mice
    Hudry, Eloise
    Van Dam, Debby
    Kulik, Wim
    De Deyn, Peter Paul
    Stet, Femke
    Ahouansou, Ornella
    Benraiss, Abdellatif
    Delacourte, Andre
    Bougneres, Pierre
    Aubourg, Patrick
    Cartier, Nathalie
    HUMAN GENE THERAPY, 2008, 19 (10) : 1085 - 1086
  • [3] AAV Gene Therapy with Cholesterol 24-Hydroxylase Reverses Alzheimer Phenotype of APP23 Mouse Model
    Hudry, Eloise
    Van Dam, Debby
    Kulik, Wim
    De Deyn, Peter P.
    Stet, Femke F.
    Ahouansou, Ornella
    Benraiss, Abdellatif
    Delacourte, Andre
    Bougneres, Pierre
    Aubourg, Patrick
    Cartier, Nathalie
    MOLECULAR THERAPY, 2009, 17 : S148 - S148
  • [4] Adeno-associated Virus Gene Therapy With Cholesterol 24-Hydroxylase Reduces the Amyloid Pathology Before or After the Onset of Amyloid Plaques in Mouse Models of Alzheimer's Disease
    Hudry, Eloise
    Van Dam, Debby
    Kulik, Wim
    De Deyn, Peter P.
    Stet, Femke S.
    Ahouansou, Ornella
    Benraiss, Abdellatif
    Delacourte, Andre
    Bougneres, Pierre
    Aubourg, Patrick
    Cartier, Nathalie
    MOLECULAR THERAPY, 2010, 18 (01) : 44 - 53
  • [5] Cholesterol 24-hydroxylase defect is implicated in memory impairments associated with Alzheimer-like Tau pathology
    Burlot, Marie-Anne
    Braudeau, Jerome
    Michaelsen-Preusse, Kristin
    Potier, Brigitte
    Ayciriex, Sophie
    Varin, Jennifer
    Gautier, Benoit
    Djelti, Fathia
    Audrain, Mickael
    Dauphinot, Luce
    Fernandez-Gomez, Francisco-Jose
    Caillierez, Raphaelle
    Laprevote, Olivier
    Bieche, Ivan
    Auzeil, Nicolas
    Potier, Marie-Claude
    Dutar, Patrick
    Korte, Martin
    Buee, Luc
    Blum, David
    Cartier, Nathalie
    HUMAN MOLECULAR GENETICS, 2015, 24 (21) : 5965 - 5976
  • [6] Differential expression of cholesterol 24-hydroxylase and cholesterol 27-hydroxylase in Alzheimer's disease
    Wolozin, B
    Brown, J
    Silberman, S
    Theisler, C
    Yager, D
    Crawley, J
    Magnuson, D
    Reiss, A
    Lee, JM
    NEUROBIOLOGY OF AGING, 2004, 25 : S529 - S529
  • [7] Cholesterol 24-hydroxylase and apolipoprotein E gene polymorphisms in Alzheimer's disease in Hungarian population
    Juhász, A
    Rimanóczy, A
    Zana, M
    Bjelik, A
    Kálmán, J
    Gálfi, M
    Janka, Z
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S609 - S609
  • [8] Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease
    Desai, P
    DeKosky, ST
    Kamboh, MI
    NEUROSCIENCE LETTERS, 2002, 328 (01) : 9 - 12
  • [9] Consequences of in vivo inhibition of Cholesterol 24-hydroxylase function: insight into the mechanism of CYP46A1-linked genetic susceptibility to Alzheimer Disease
    Djelti, Fathia
    Hudry, Eloise
    Varin, Jennifer
    Aycierex, Sophie
    Bieche, Ivan
    Auzeuil, Nicolas
    Aubourg, Patrick
    Cartier, Nathalie
    HUMAN GENE THERAPY, 2012, 23 (10) : A64 - A65
  • [10] Polymorphisms of the cholesterol 24-hydroxylase (CYP46A1) gene and the risk of Alzheimer's disease in a Chinese population
    Ma, Suk Ling
    Tang, Nelson Leung Sang
    Lam, Linda Chiu Wa
    Chiu, Helen Fung Kum
    INTERNATIONAL PSYCHOGERIATRICS, 2006, 18 (01) : 37 - 45
123